In the context of epithelial differentiation, the authors have identified the cell cycle inhibitor p27KIP1 (CDKN1B) as a target of KLF4, through which proliferation of pancreatic cancer cells was blocked [93]. Here, CDKN1B is linked to pancreatic neoplasm.